Pacific Biosciences of California, Inc. Income (Loss) from Continuing Operations before Income Taxes, Domestic
Pacific Biosciences of California, Inc. (PACB) reported Income (Loss) from Continuing Operations before Income Taxes, Domestic of -$547.50 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-25.
Financial Statements › Income Statement › Pre-tax Income
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic · last filed 2026-02-25
- Pacific Biosciences of California, Inc. income (loss) from continuing operations before income taxes, domestic for fiscal 2025 was -$547.50M.
- Pacific Biosciences of California, Inc. income (loss) from continuing operations before income taxes, domestic for fiscal 2024 was -$311.00M.
- Pacific Biosciences of California, Inc. income (loss) from continuing operations before income taxes, domestic for fiscal 2023 was -$318.90M.
- Pacific Biosciences of California, Inc. income (loss) from continuing operations before income taxes, domestic for fiscal 2022 was -$315.70M.
| Period end | Income (Loss) from Continuing Operations before Income Taxes, Domestic 12 month | Income (Loss) from Continuing Operations before Income Taxes, Domestic 12 month as first filed |
|---|---|---|
| 2025-12-31 | -$547.50M 10-K · filed 2026-02-25 | |
| 2024-12-31 | -$311.00M 10-K · filed 2026-02-25 | |
| 2023-12-31 | -$318.90M 10-K · filed 2026-02-25 | |
| 2022-12-31 | -$315.70M 10-K · filed 2025-03-17 | |
| 2021-12-31 | -$275.40M 10-K · filed 2024-02-28 | |
| 2020-12-31 | -$28.90M 10-K · filed 2023-02-28 | $28.90M 10-K · filed 2021-02-26 |
| 2019-12-31 | -$84.80M 10-K · filed 2022-02-28 | |
| 2018-12-31 | -$103.10M 10-K · filed 2021-02-26 | |
| 2017-12-31 | -$92.70M 10-K · filed 2020-02-28 | |
| 2016-12-31 | -$74.00M 10-K · filed 2019-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B |